We’re experiencing issues with our datasets and search. We apologise for any inconvenience while we work to fix this.
AusPAR: Nuvaxovid heterologous booster
Device/Product Name
Nuvaxovid heterologous booster
Active ingredients
SARS-CoV-2 rS vaccine with Matrix-M1 adjuvant
AusPAR Date
Published
Sponsor
Submission Number
PM-2022-00638-1-2
Submission Type
Major variation (change in dose regimen)
Decision
Approved for provisional registration